Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252902 · ClinicalTrials.gov registry record · Phase 1
Emergency Department Initiated Tobacco Treatment (EDITT)
A Phase 1 study of Tobacco Use, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00252902: Completed Phase 1 study of Tobacco Use, sponsored by National Institute on Drug Abuse (NIDA).
NCT00252902 is a Phase 1 study of Tobacco Use that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 75 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00252902, a Phase 1 study of Tobacco Use, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of the study is to refine the intervention protocols for two ED-initiated tobacco interventions and to assess the magnitude of the effect size that can be expected. We expect the intervention groups to have greater sustained abstinence, point-prevalence abstinence, and motivation to change when compared to the treatment as usual group at 1- and 3-month follow-up.
Conditions Studied
Interventions
- BEHAVIORAL Behavior change counseling
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
What the finished NCT00252902 record still lists
NCT00252902 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 1 intervention - of which Behavior change counseling is the first listed.
NCT00252902 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00252902 about?
NCT00252902 is a clinical study titled "Emergency Department Initiated Tobacco Treatment (EDITT)". The primary purpose of the study is to refine the intervention protocols for two ED-initiated tobacco interventions and to assess the magnitude of the effect size that can be expected. We expect the intervention groups to have greater sustained abstinence, point-prevalence abstinence, and motivation...
What is the current status of trial NCT00252902?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2005-12. Estimated completion is 2007-12.
What conditions does trial NCT00252902 study?
This clinical trial studies the following conditions: Tobacco Use.
What interventions are being tested in trial NCT00252902?
The interventions under investigation include: Behavior change counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00252902?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00252902 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00252902's enrollment target sits among peer trials
75 42nd of 76 higher than 34 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Oral Cannabidiol for Tobacco Cessation
RECRUITING · Phase 1
-
Effect of Cannabis on E-Cigarette Use Behavior
RECRUITING · Phase 1
-
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
COMPLETED · Phase 1
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia